Error loading player: No playable sources found

3545

Liver & Biliary (LB) Section Distinguished Abstract Plenary

Date
May 4, 2025
Explore related products in the following collection:

Society: AGA

This session features the top abstracts submitted and reviewed by the Liver & Biliary (LB) section, showcasing cutting-edge research and advancements in liver and biliary diseases. Attendees will gain insights into genetic and clinical predictors of mortality in steatotic liver disease, the impact of nutritional therapy on frailty status in cirrhotic patients, and the efficacy and safety of novel treatments for primary biliary cholangitis and hepatocellular carcinoma. Additionally, the session will explore the use of AI models for predicting advanced liver fibrosis and cardiovascular mortality in MASLD.

Moderators

Speaker Image for Ashwani Singal
University of Alabama at Birmingham
Speaker Image for Don Rockey
Medical University of South Carolina, Dept. of Internal Medicine

Related Products

Thumbnail for Diagnosis and Management of Early Alcohol-Associated Liver Disease
Diagnosis and Management of Early Alcohol-Associated Liver Disease
Alcohol-associated liver disease (ALD) and alcohol use disorder (AUD) are often concomitant diseases. Compared to other liver disease, ALD often presents at an advanced stage and after presentation progresses faster to decompensation with a reduced patient survival…
Thumbnail for Endoscopy for Portal Hypertension, Complications of Cirrhosis, and GI Bleeding
Endoscopy for Portal Hypertension, Complications of Cirrhosis, and GI Bleeding
Delve into the latest advancements in managing portal hypertension, complications of cirrhosis, and GI bleeding through endoscopic interventions…